|
Publication |
|
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1. Zhou X, Han S, Cebulla N, Haertle L, Steinhardt MJ, Schirmer D, Runau E, Flamm L, Terhorst C, Jähnel L, Vogt C, Nerreter S, Teufel E, Stanojkovska E, Mersi J, Munawar U, Schindehütte M, Blum R, Reinhold AK, Scherf-Clavel O, Rittner HL, Pham M, Rasche L, Einsele H, Sommer C, Kortüm KM. Biomark Res. 2023 May 16;11(1):52. doi: 10.1186/s40364-023-00490-9.
|
|
Systemic inflammatory markers in patients with polyneuropathies. García-Fernández P, Höfflin K, Rausch A, Strommer K, Neumann A, Cebulla N, Reinhold AK, Rittner H, Üçeyler N, Sommer C. Front Immunol. 2023 Feb 13;14:1067714. doi: 10.3389/fimmu.2023.1067714. eCollection 2023.
|
|
Neurofilament light chain levels indicate acute axonal damage under bortezomib treatment. Cebulla N, Schirmer D, Runau E, Flamm L, Gommersbach S, Stengel H, Zhou X, Einsele H, Reinhold AK, Rogalla von Bieberstein B, Zeller D, Rittner H, Kortüm KM, Sommer C. J Neurol. 2023 Jun;270(6):2997-3007. doi: 10.1007/s00415-023-11624-2. Epub 2023 Feb 18.
|
|
Synthesis and Characterization of Citrate-Stabilized Gold-Coated Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications.Stein R, Friedrich B, Mühlberger M, Cebulla N, Schreiber E, Tietze R, Cicha I, Alexiou C, Dutz S, Boccaccini AR, Unterweger H. Molecules. 2020 Sep 26;25(19):4425. doi: 10.3390/molecules25194425.
|
|
Functionalization Of T Lymphocytes With Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles For Magnetically Controlled Immune Therapy.Mühlberger M, Janko C, Unterweger H, Friedrich RP, Friedrich B, Band J, Cebulla N, Alexiou C, Dudziak D, Lee G, Tietze R. Int J Nanomedicine. 2019 Oct 24;14:8421-8432. doi: 10.2147/IJN.S218488. eCollection 2019.
|
|
| | Last update Publications 20.05.2023 |
|